Advanced search
Publication Cover
Patient Preference and Adherence Volume 15, 2021 - Issue
Submit an article Journal homepage
406
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in a Large International Rheumatoid Arthritis Cohort: SENSE Study

Peter C Taylor1 Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7766-6167View further author information
ORCID Icon,
Codrina Ancuta2 Department of Rheumatology, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, RomaniaView further author information
,
Orsolya Nagy3 AbbVie Inc, North Chicago, IL, USAView further author information
,
María C de la Vega4 CEIM Investigaciones Medicas, Buenos Aires, ArgentinaView further author information
,
Andrey Gordeev5 V.A. Nasonova Research Institute of Rheumatology, Moscow, Russian FederationView further author information
,
Radka Janková6 Department of Pediatric and Adult Rheumatology, Faculty Hospital Motol, Prague, Czech RepublicView further author information
,
Umut Kalyoncu7 Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, TurkeyView further author information
,
Ivan Lagunes-Galindo3 AbbVie Inc, North Chicago, IL, USAView further author information
,
Jadranka Morović-Vergles8 Department of Internal Medicine, Division of Clinical Immunology, Allergology and Rheumatology, Dubrava University Hospital, University of Zagreb School of Medicine, Zagreb, CroatiaView further author information
,
Mariana Peixoto G U e Silva de Souza9 Santa Casa de Belo Horizonte, Belo Horizonte, BrazilView further author information
,
Bernadette Rojkovich10 Department of Rheumatology and Physiotherapy, Polyclinic of the Hospitaller Brothers of St. John of God, Semmelweis University, Budapest, HungaryView further author information
,
Prodromos Sidiropoulos11 Faculty of Medicine, University of Crete, Heraklion, GreeceView further author information
&
Atsushi Kawakami12 Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, JapanView further author information
 show all
Pages 359-373 | Published online: 17 Feb 2021

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yoshiya Tanaka. (2023) Ozoralizumab: first Nanobody® therapeutic for rheumatoid arthritis. Expert Opinion on Biological Therapy 23:7, pages 579-587.
Read now

Articles from other publishers (14)

Seong-Kyu Kim, Sang-Heon Lee, Jiyu Sun, Soo Hyun Lee, Ja-Young Jeon, Hyun-Jeong Yoo & Jung-Yoon Choe. (2023) Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumab. Arthritis Research & Therapy 25:1.
Crossref
Christos Ermeidis, Theodoros Dimitroulas, Chryssa Pourzitaki, Paraskevi V. Voulgari & Dimitrios Kouvelas. (2023) Perceived treatment satisfaction in patients with systemic rheumatic diseases treated with biologic therapies: results of a self-reported survey. Rheumatology International 43:6, pages 1151-1159.
Crossref
Samantha Hider, Sara Muller, Lauren Gray, Fay Manning, Mike Brooks, Dominic Heining, Ajit Menon, Jonathan Packham, Subhra Raghuvanshi, Edward Roddy, Sarah Ryan, Ian Scott & Zoe Paskins. (2023) Digital exclusion as a potential cause of inequalities in access to care: a survey in people with inflammatory rheumatic diseases. Rheumatology Advances in Practice 7:1.
Crossref
Peter C. Taylor, Bruno Fautrel, Yves Piette, Susana Romero-Yuste, Jasper Broen, Martin Welcker, Oliver Howell, Elke Rottier, Monia Zignani, Katrien Van Beneden, Roberto Caporali & Rieke Alten. (2022) Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe. RMD Open 8:2, pages e002658.
Crossref
A. E. Karateev. (2022) Analgesics in rheumatic diseases – a necessary component of therapy aimed at improving the quality of life. Modern Rheumatology Journal 16:5, pages 101-107.
Crossref
John M. DavisIIIIII. (2022) The Patient Experience of Drug Side Effects in Rheumatoid Arthritis: Intriguing Data From an Exploratory Online Survey. The Journal of Rheumatology 49:9, pages 967-970.
Crossref
Jiu Liang Zhao, Xin Liu, Jin Nan Li, Meng Ru Liu, Elke Rottier, Yan Zhao & Xiao Feng Zeng. (2022) Implementation of the treat-to-target approach and treatment satisfaction in patients with rheumatoid arthritis: perspectives of Chinese rheumatologists. Clinical Rheumatology 41:9, pages 2659-2668.
Crossref
Dalton Sholter, Jianmin Wu, Bochao Jia, Hong Zhang, Kirstin Griffing, Julie Birt, Paulo Jorge Simoes Reis, Huaxiang Liu & Clifton O. BinghamIIIIII. (2022) Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials. Rheumatology and Therapy 9:2, pages 541-553.
Crossref
Cho-Hsun Hsieh, Yi-Wei Huang & Tsen-Fang Tsai. (2022) Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review. Dermatology and Therapy 12:4, pages 835-860.
Crossref
Toshifumi Fujiwara, Masakazu Kondo, Hisakata Yamada, Akihisa Haraguchi, Kenjiro Fujimura, Koji Sakuraba, Satoshi Kamura, Jun-ichi Fukushi, Hisaaki Miyahara, Yasushi Inoue, Tomomi Tsuru, Toshihide Shuto, Seiji Yoshizawa, Eiichi Suematsu, Tomoya Miyamura, Masahiro Ayano, Hiroki Mitoma, Yojiro Arinobu, Hiroaki Niiro, Masanobu Ohishi, Akie Hirata, Shoji Tokunaga, Atsushi Takada, Daisuke Hara, Hidetoshi Tsushima, Yukio Akasaki, Satoshi Ikemura, Takuya Sueishi, Masakazu Toya, Takahide Sakuragi, Tomoko Tsutsui, Kazuhiro Kai, Shinkichi Arisumi & Yasuharu Nakashima. (2022) Factors affecting patient satisfaction related to cost and treatment effectiveness in rheumatoid arthritis: results from the multicenter observational cohort study, FRANK Registry. Arthritis Research & Therapy 24:1.
Crossref
Peter C. Taylor, Marco Matucci Cerinic, Rieke Alten, Jérôme Avouac & Rene Westhovens. (2022) Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2211141.
Crossref
Yutaka Kawahito, Yuya Takakubo, Akio Morinobu, Naoko Matsubara, Orsolya Nagy & Eiji Sugiyama. (2021) Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE). PLOS ONE 16:11, pages e0259389.
Crossref
T I Okonenko, A K Khrutskiy, A B Yershevskaya, A V Ivanova, G A Antropova & E E Rumyantsev. (2021) Modern Genetic Engineering Technology Achievements in Rheumatology. IOP Conference Series: Earth and Environmental Science 852:1, pages 012075.
Crossref
E. Yu. Pogozheva, A. E. Karateev, N. A. Bulgakova, V. N. Amirdzhanova, E. S. Filatova, V. A. Nesterenko & A. M. Lila. (2021) Satisfaction with analgesic therapy in patients with rheumatic diseases in real clinical practice, according to the KOMPAS study (Quality of Pain Relief in the Opinion of Patients with Arthritis and Back Pain). Modern Rheumatology Journal 15:4, pages 43-49.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.